Gray stock: Oct. 27, 2020 | Pump and dump?

March 21, 2021

Here is the article. 

Last on Needham’s value list is Graybug, a biopharmaceutical firm conducting clinical-stage research on medications to treat chronic diseases of the retina and optic nerve. The company focuses on long-term treatments, with drugs to be administered no more than twice per year – and provide relief from vision loss due to age-related macular degeneration and diabetic macular edema.

Graybug’s IPO in September was notably successful; the company started trading at $16 per share, above the $15 originally planned, and sold almost 1 million more shares than first announced.

Biotech firms are famously mercurial as stock investments. They tend to run deep losses for long periods, as medical research is both expensive and impossible to short cut. The rewards, however, are real, as one popular drug, or a treatment that is perceived as essential, can bring in tremendous profits once it goes on the market. That’s the value Needham sees here.

Starting coverage on this stock for Needham is analyst Serge Belanger, who says of GRAY, “Anti-VEGF therapies generate ~$12B in WW sales as the standard of care for retinal diseases despite 40%-50% of patients experiencing inadequate responses and a treatment burden that impacts patient compliance. We believe [the company's] GB-102 can disrupt the anti-VEGF market with a differentiated mechanism of action and longer-dosing intervals. Upcoming ph 2b trial data in 1H21 represent the most near-term value-driving catalyst.”

In line with his outlook, Belanger rates the stock a Buy. His $30 price target represents an impressive 96% upside potential for the year ahead. (To watch Belanger’s track record, click here)

Wall Street agrees that GRAY is a buying proposition. The stock has 6 recent reviews, and all are Buys, making the Strong Buy consensus rating unanimous. Shares are selling for $15.32, and the $32.50 average price target implies an upside of 115%. (See GRAY stock analysis on TipRanks)

GRAY stock

Stock research: If I want to be a millionaire in Canada?

June 7, 2020

Introduction

I like to do a short research about the topic called stock research, "If I want to be a millionaire in Canada?". 

My short research

I have a stable job last 10 years, and then first time in my life I can have stable job last 10 years, never worry about job change too much, and enjoy to hold cash as investment in stock market over $100,000 dollars, including $28,000 US dollars in my US retirement account, and also $77,000 dollars in market value on June 7, 2020. 

How can I want to be a millionaire in Canada?

It is very tough for me since I find out the investment group in any form is a different crowd. They are not Christian group, pray together; they are not business group, they can easy form the business relationship. Also there are more. 

I came cross this severe allergy third year, and my employer talked about twice that I have to learn how to take care of it. I focused on medication using strong medicine anti-hestamine, but I doubted that the effect related to my mood, my weight, and my decision making process. 

It is my next research topic related to this medicine. I like to have relax Sunday life back, attend the church, enjoy the laugh and learning, and big audience to get together with other people. 

I did purchase OVV.TO stock on March 27, 2020 100 share $3.7, and kept it, after two months, it is four times more. I did not and was afraid to add more money, even a small amount $5,000 or $10,000 dollars next two months, I was afraid so many things. Job I worked on, allergy I learned to cope with, the nervousness I brought to the office, and all other things related to my relatives, the curse from my young sister and I tried to fight against prejudice from all my siblings. 

I have $86,000 dollars in the stock market from March 27, 2020, and also more on bank accounts. But I was not ready to move myself outside the comfortable zone. I could not find a person to pray together, and talk about in detail 10 to 15 minutes about the positions I hold. 

I am ashamed to bring myself into this situation, isolation and disconnect to others who are good and supportive. 

I did think about hiring a profession SJTU young alumni to review my portfolio with me $1 dollar a minute. I did not take action on April 20, 2020 after consultation with the wechat group JTU. 

Here are highlights:

1. Good research to find right time right stocks like OVV.TO 90% loss;
2. Understand the market risk and also willing to take risk - OVV may go bankrupt, same as other distress stocks and those companies which went out index fund and challenging survival. 
3. Good health, keep an eye on medication like anti-hestimine, if it will affect my mood, decision making; 
4. Understand that even if my positions went down over $10,000 dollars, that is the time to move bond fund to purchase those distressed stocks; It is the same as hard work like working in labor work, restaurant, and other places; 
5. I can take some risk, frugal and minimalism as I can last 12 months, risk $20,000 to $30,000 dollars to purchase those stocks. 
6. Go back to regular Sunday worship service, relax my nerve and enjoy the life;
7. Investment is not so tough and I do not need to be market genius, and follow so many CNBC, yahoo finance articles. 
8. Make a small move to double the money in $10,000 in a few distressed stocks, build muscle money. 
9. Do not care too much about market value when bear market, check positions I have;
10. Do not time the market and try to be market genius, hold on long term partnership with those businesses in the world. 

I only have positions with gains $2,600 dollars in $64,000 dollars investment on TFSA after over 12 months. The journey is tough and I will try to take breaks and slow down. 

Millionaire dream is possible. Keep reaching out to help others, learn investment basics, and help others. Form a good community and keep working hard. 

References:

Thanks all those business brand names: Charles Schwab, Questrade, Yahoo finance, Intuit mint, Ameritrade, Personal capital, Sharesight

Charles Schwab

Questrade.com

Intuit
Mint app

Sharesight

Yahoo finance